NCT02720757View on ClinicalTrials.gov

Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO)

TerminatedOBSERVATIONAL
Enrollment

132

Participants

Timeline

Start Date

August 26, 2016

Primary Completion Date

December 14, 2017

Study Completion Date

December 14, 2017

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Spiolto Respimat

Tiotropium bromide + Olodaterol

Trial Locations (6)

Unknown

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

One Or Multiple Investigational Sites

One Or Multiple Investigational Site

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02720757 - Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO) | Biotech Hunter | Biotech Hunter